Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 12, Issue 1, 2013, Pages 29-34

  Proesmans, M ^a   Vermeulen, F ^a   Boulanger, L ^a   Verhaegen, J ^a   De Boeck, K ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cystic fibrosis; Eradication; Lung infection; Pseudomonas aeruginosa

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COLISTIMETHATE; COLISTINEB; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHRONICITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; COUGHING; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG WITHDRAWAL; ERADICATION THERAPY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHUMAN; OPEN STUDY; OUTCOME ASSESSMENT; PSEUDOMONAS INFECTION; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; COLISTIN; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; SPUTUM; TOBRAMYCIN; TREATMENT OUTCOME;

EID: 84870742117     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.06.001     Document Type: Article

References (25)

1. Emerson J., Rosenfeld M., McNamara S., Ramsey B., Gibson R.L. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002, 34:91-100.
2. Kosorok M.R., Zeng L., West S.E., Rock M.J., Splaingard M.L., Laxova A., et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001, 32:277-287.
3. Li Z., Kosorok M.R., Farrell P.M., Laxova A., West S.E., Green C.G., et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005, 293:581-588.
4. Valerius N.H., Koch C., Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991, 338:725-726.
5. Frederiksen B., Koch C., Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997, 23:330-335.
6. Elborn J.S., Hodson M., Bertram C. Implementation of European standards of care for cystic fibrosis - provision of care. J Cyst Fibros 2009, 8:348-355.
7. Ratjen F., Munck A., Kho P., Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax 2010, 65:286-291.
8. Treggiari M.M., Retsch-Bogart G., Mayer-Hamblett N., Khan U., Kulich M., Kronmal R., et al. Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med 2011, 165:847-856.
9. Littlewood J.M., Miller M.G., Ghoneim A.T., Ramsden C.H. Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet 1985, 1:865.
10. Munck A., Bonacorsi S., Mariani-Kurkdjian P., Lebourgeois M., Gerardin M., Brahimi N., et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr Pulmonol 2001, 32:288-292.
11. Ratjen F., Doring G., Nikolaizik W.H. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet 2001, 358:983-984.
12. Taccetti G., Campana S., Festini F., Mascherini M., Doring G. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2005, 26:458-461.
13. Wiesemann H.G., Steinkamp G., Ratjen F., Bauernfeind A., Przyklenk B., Doring G., et al. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Pediatr Pulmonol 1998, 25:88-92.
14. Gibson R.L., Emerson J., McNamara S., Burns J.L., Rosenfeld M., Yunker A., et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med 2003, 167:841-849.
15. Gibson R.L., Emerson J., Mayer-Hamblett N., Burns J.L., McNamara S., Accurso F.J., et al. Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol 2007, 42:610-623.
16. Hansen C.R., Pressler T., Hoiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15years experience. J Cyst Fibros 2008, 7:523-530.
17. Hoiby N., Frederiksen B., Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 2005, 4(Suppl. 2):49-54.
18. Lee T.W., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2:29-34.
19. Proesmans M., Balinska-Miskiewicz W., Dupont L., Bossuyt X., Verhaegen J., Hoiby N., et al. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 2006, 27:937-943.
20. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18years of age. Pediatr Pulmonol 1993, 15:75-88.
21. Hampel B., Hullmann R., Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use - safety report. Pediatr Infect Dis J 1997, 16:127-129. [discussion 60-2].
22. Taccetti G., Bianchini E., Cariani L., Buzzetti R., Costantini D., Trevisan F., et al. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. Thorax 2012, [Epub].
23. Brochet M.S., McDuff A.C., Bussieres J.F., Caron E., Fortin G., Lebel D., et al. Comparative efficacy of two doses of nebulized colistimethate in the eradication of Pseudomonas aeruginosa in children with cystic fibrosis. Can Respir J 2007, 14:473-479.
24. Langton Hewer S.C., Smyth A.R. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev 2009, CD004197.
25. Schelstraete P., Deschaght P., Van Simaey L., et al. Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients. J Cyst Fibros 2009, 9:99-103.